RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $231,000 | +4520.0% | 41,900 | +5137.5% | 0.00% | – |
| Q4 2021 | $5,000 | -64.3% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | -99.1% | 800 | -98.8% | 0.00% | -100.0% |
| Q2 2021 | $1,606,000 | +80200.0% | 65,800 | +13608.3% | 0.01% | – |
| Q3 2020 | $2,000 | -33.3% | 480 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 480 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |